You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Partial Responder

Showing 1 - 25 of 3,893
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alcoholic Hepatitis Trial in Chuncheon (G-CSF (Filgrastim injection), steroid, )

Terminated
  • Alcoholic Hepatitis
  • G-CSF (Filgrastim injection)
  • +2 more
  • Chuncheon, Korea, Republic of
    Chuncheon Sacred Heart hospital
Aug 4, 2022

PD-1 Refractory Advanced Melanoma Trial in Pittsburgh (Responder-Derived Fecal microbiota transplantation (R-FMT, Pembrolizumab,

Not yet recruiting
  • PD-1 Refractory Advanced Melanoma
  • Responder-Derived Fecal microbiota transplantation (R-FMT
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Sep 1, 2023

Environmental Mycobiota: In-depth Characterisation and

Not yet recruiting
  • Asthma
  • Assessment of the microbial exposome
  • Bourdeaux, France
  • +1 more
Apr 4, 2023

Safety of Perampanel When Used as First Add-on Therapy in

Active, not recruiting
  • Idiopathic Generalized Epilepsy
  • +2 more
  • Esbjerg, South Denmark, Denmark
  • +35 more
Jan 10, 2023

Epilepsy, Partial Seizure, Neurostimulator; Complications Trial in United States (RNS System)

Recruiting
  • Epilepsy
  • +4 more
  • RNS System
  • Orange, California
  • +9 more
Aug 3, 2022

Non Small Cell Lung Cancer Trial in Pittsburgh (Fecal Microbiota Transplant (FMT), Pembrolizumab)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Dec 20, 2022

Focal Epilepsy Trial (ENX-101)

Not yet recruiting
  • Focal Epilepsy
  • (no location specified)
Jul 28, 2022

Epilepsy Trial in Korea, Republic of (zonisamide)

Completed
Has Results
  • Epilepsy
  • Busan, Korea, Republic of
  • +9 more
Dec 10, 2021

Emergency Responders in Different States

Recruiting
  • Heart Rate Monitoring
  • vital signs monitoring
  • Jinan, Shan Dong, China
    Qilu Hospital of Shandong University
Oct 6, 2023

Epilepsy Trial in Worldwide (Placebo, Brivaracetam, Antiepileptic drugs with market authorization available per country)

Completed
Has Results
  • Epilepsy
  • Placebo
  • +2 more
  • Phoenix, Arizona
  • +206 more
Jul 14, 2022

Individuals With Bipolar I Disorder: The R-LiNK Initiative

Active, not recruiting
  • Bipolar I Disorder
  • lithium treatment
  • Paris, France
    Hôpital Fernand Widal
Jul 12, 2022

Epilepsy Trial in Worldwide (Placebo, Brivaracetam)

Completed
Has Results
  • Epilepsy
  • Gent, Belgium
  • +75 more
Jul 14, 2022

Moderate to Severe Ulcerative Colitis Patients Treated With

Recruiting
  • Ulcerative Colitis
  • Inflammatory Bowel Diseases
  • Procedure: endoscopic biopsy
  • +2 more
  • Nancy, Lorraine, France
    Central Hospital
Jul 11, 2022

Chronic Hepatitis C Trial in Parma (blood drawing)

Completed
  • Chronic Hepatitis C
  • blood drawing
  • Parma, Italy
    Unit of Infectious Diseases and Hepatology
Jul 20, 2021

MDD Trial in Gwangju (stepwise pharamacotherapy, antidepressant monotherapy group)

Recruiting
  • Major Depressive Disorder
  • stepwise pharamacotherapy
  • antidepressant monotherapy group
  • Gwangju, Korea, Republic of
    Chonnam National University Hospital
Sep 19, 2023

Refractory Cancer, Relapsed Cancer Trial in Weston (Drug Sensitivity Test (DST))

Not yet recruiting
  • Refractory Cancer
  • Relapsed Cancer
  • Drug Sensitivity Test (DST)
  • Weston, Florida
    Lerner College of Medicine: Cleveland Clinic Florida
Sep 1, 2023

Ulcerative Colitis Trial in Lake Success (RAVANS, RAVANS-sham)

Recruiting
  • Ulcerative Colitis
  • RAVANS
  • RAVANS-sham
  • Lake Success, New York
    Feinstein Institute for Medical Research at Northwell Health
Jan 17, 2023

Partial-Onset or Primary Generalized Tonic-Clonic Seizures Trial in Worldwide (Perampanel)

Completed
Has Results
  • Partial-Onset or Primary Generalized Tonic-Clonic Seizures
  • Little Rock, Arkansas
  • +91 more
Jan 11, 2022

Hepatorenal Syndrome, Acute Kidney Injury Trial in United States (R2R01, Terlipressin)

Not yet recruiting
  • Hepatorenal Syndrome
  • Acute Kidney Injury
  • San Francisco, California
  • +6 more
May 16, 2023

Response to Gemcitabine Chemotherapy in Mycosis Fungoides

Recruiting
  • Lymphoma, T-Cell, Cutaneous
  • Mycosis Fungoides
  • single-arm, non-randomized Biodynamic imaging (BDI)
  • Indianapolis, Indiana
    Indiana University School of Medicine, Department of Dermatology
Nov 16, 2022

Evaluate Safety and Efficacy of Cosentyx in Pediatric PsV, PsA,

Recruiting
  • Psoriasis Vulgaris
  • +2 more
  • Cosentyx
  • Nagoya-city, Aichi, Japan
  • +23 more
Aug 3, 2022

Highly Drug-resistant Focal Epilepsy Trial in Worldwide (UCB0942)

Terminated
Has Results
  • Highly Drug-resistant Focal Epilepsy
  • Brussels, Belgium
  • +14 more
Mar 8, 2022

Plaque Psoriasis Trial (Tildrakizumab 200 mg, Tildrakizumab 100 mg, Tildrakizumab Placebo)

Completed
Has Results
  • Plaque Psoriasis
  • Tildrakizumab 200 mg
  • +4 more
  • (no location specified)
Feb 23, 2022

Epilepsy Trial (Perampanel)

Not yet recruiting
  • Epilepsy
  • (no location specified)
Sep 6, 2022

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent DLBCL, Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma Trial

Active, not recruiting
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +7 more
  • Jacksonville, Florida
  • +11 more
Jan 12, 2023